FAS and gastric cancer: For GC patients, our results showed that many subgroups, including age, tumor size and site, tumor differentiation, histological types, lymph node metastasis, invasion depth and TNM stage had significant effects on the prognosis of chemotherapy patients with FAS 1377 GA + AA or 670 GA + GG genotypes (Table 3).